Goldman Sachs
CYTR

Goldman Sachs’s CytRx Corp CYTR Stock Holding History

Goldman Sachs’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-22,617
Closed -$345K – 7613
2014
Q3 		$345K Hold
22,617
– – ﹤0.01% 5628
2014
Q2 		$567K Buy
22,617
+167
+0.7% +$3.81K ﹤0.01% 5194
2014
Q1 		$470K Hold
22,450
– – ﹤0.01% 5339
2013
Q4 		$845K Buy
22,450
+1,950
+10% +$35.5K ﹤0.01% 4882
2013
Q3 		$397K Buy
+20,500
New +$302K ﹤0.01% 5339

Other funds holding CYTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Goldman Sachs's CYTR Position: Q4 2017 in Review

Goldman Sachs sold out of CytRx Corp (CYTR) in Q4 2017, closing a stake of 5,947 shares — an estimated $15K sold.

Goldman Sachs first reported a position in CYTR in Q3 2013 and held it in 16 quarters. The position peaked at $441K in Q2 2017. 33 funds tracked by Wall St. Rank hold CYTR as of Q4 2017.

  • Goldman Sachs reported no remaining CytRx Corp position as of Q4 2017 after selling out during the quarter.
  • Goldman Sachs sold 5,947 CytRx Corp shares in Q4 2017, an estimated $15K.
  • Goldman Sachs first reported a position in CytRx Corp in Q3 2013 and held it in 16 quarters.
  • Goldman Sachs's CytRx Corp position peaked at $441K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2017.

Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.